Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001072613-03-000491
Filing Date
2003-03-25
Accepted
2003-03-25 17:02:20
Documents
9
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 ABLE LABORATORIES, INC. FORM 10-K ableform10-k_11808.htm 10-K 859564
3 DIRECTOR STOCK OPTION FOR WADEKAR ex10-16_11808.txt EX-10.16 18513
4 DIRECTOR STOCK OPTION FOR KLINT ex10-17_11808.txt EX-10.17 18441
5 DIRECTOR STOCK OPTION FOR SILVERMAN ex10-18_11808.txt EX-10.18 18446
6 DIRECTOR STOCK OPTION FOR SCHNEIDER ex10-19_11808.txt EX-10.19 18479
7 DIRECTOR STOCK OPTION FOR TREPPEL ex10-20_11808.txt EX-10.20 18038
8 DIRECTOR STOCK OPTION FOR WEINSTEIN ex10-21_11808.txt EX-10.21 18039
9 SUBSIDIARIES OF THE REGISTRANT ex21-1_11808.txt EX-21.1 248
10 CONSENT OF WOLF & COMPANY, P.C. ex23-1_11808.txt EX-23.1 771
  Complete submission text file 0001072613-03-000491.txt   973292
Mailing Address 6 HOLLYWOOD COURT . SOUTH PLAINFIELD NJ 07080
Business Address 6 HOLLYWOOD COURT . SOUTH PLAINFIELD NJ 07080 908-754-2253
ABLE LABORATORIES INC (Filer) CIK: 0000857171 (see all company filings)

EIN.: 330659916 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-11352 | Film No.: 03616224
SIC: 2835 In Vitro & In Vivo Diagnostic Substances